With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to the market.
Trump
Administration
Supported by
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to the market.
By Christina Jewett
A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.
Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and…
Monitoring trials in real time may help shorten the time interval between trial phases.
It's the Trump administration's latest move to rein in high prescription drug costs in the U.S., and could be a blow to…
The White House says the action plan will boost US innovation and promote American AI technology globally.
An agency-wide LLM called Elsa was released weeks ahead of schedule.
